Compounding pharmacies make customized medicines for individual patients, and under section 503A of the Food, Drug, and Cosmetic Act, a pharmacy can compound from a bulk substance only if that substance has an official quality monograph, is a component of an FDA-approved drug, or has been formally added to an approved bulks list. BPC-157 qualifies on none of those counts, which is why the FDA placed it in Category 2 of its 503A bulk-substance review in September of 2023
S kt hp ca vitamin C, E, ALA gip ln da sng v khe mnh
Curcumin exerts this beneficial effect by reducing insulin and leptin resistance, decreasing inflammatory cytokine release, accelerating fatty acid oxidation and increasing antioxidant enzyme release
Inflammation 47 ,1313-1327 (2024)
Gastric pentadecapeptide BPC 157 as an effective therapy for muscle crush injury in the rat